Provided by Tiger Trade Technology Pte. Ltd.

Eledon Pharmaceuticals, Inc.

2.78
-0.0050-0.18%
Volume:246.16K
Turnover:683.43K
Market Cap:225.50M
PE:-2.81
High:2.86
Open:2.86
Low:2.75
Close:2.78
52wk High:4.60
52wk Low:1.35
Shares:81.26M
Float Shares:74.57M
Volume Ratio:0.53
T/O Rate:0.33%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.9867
EPS(LYR):-0.5566
ROE:-110.71%
ROA:-39.02%
PB:3.13
PE(LYR):-4.99

Loading ...

Top Premarket Gainers

MT Newswires Live
·
Yesterday

Eledon to Present Long-Term Tegoprubart Data at Transplantation Society Congress

Reuters
·
Sep 09

Analysts’ Top Healthcare Picks: Align Tech (ALGN), Eledon Pharmaceuticals (ELDN)

TIPRANKS
·
Sep 03

Eledon Submits FDA IND for Tegoprubart Islet Cell Transplant Trial in Type 1 Diabetes

Reuters
·
Sep 03

Eledon Pharmaceuticals Announces Islet Cell Transplantation Ind Submission, First Patients Enrolled in Multiple Transplant Programs, and Reaffirms Plan to Initiate Phase 3 Kidney Transplantation Trial in Fourth Quarter 2026

THOMSON REUTERS
·
Sep 03

Clene Q2 Net Loss Widens on Higher Other Expenses

Reuters
·
Aug 14

Eledon Pharmaceuticals Inc Reports Results for the Quarter Ended June 30 - Earnings Summary

Reuters
·
Aug 14

Eledon Pharma Q2 EPS $(0.27) Misses $(0.16) Estimate

Benzinga Earnings
·
Aug 14

Eledon Pharmaceuticals Q2 Net Loss Widens on Warrant Liability Changes

Reuters
·
Aug 14

Eledon Q2 FY26 Net Loss Widens to $31.6 Million

Reuters
·
Aug 14

Eledon Pharmaceuticals Reports Second Quarter 2026 Financial Results and Recent Business Highlights

THOMSON REUTERS
·
Aug 14

Eledon Pharmaceuticals Q2 Operating Expenses USD 22.869 Million

THOMSON REUTERS
·
Aug 14

Eledon Pharmaceuticals Inc Expected to Post a Loss of 16 Cents a Share - Earnings Preview

Reuters
·
Aug 10

NewcelX Prices USD 1.4 Million Private Placement at USD 4.03 Per Share

Reuters
·
Jul 31

Here's Why We're Watching Eledon Pharmaceuticals' (NASDAQ:ELDN) Cash Burn Situation

Simply Wall St.
·
Jul 25

Eledon Pharmaceuticals Initiated at Buy by Rodman & Renshaw

Dow Jones
·
Jul 21

Natera Partners with Eledon to Supply Prospera Monitoring for Planned Phase 3 Kidney Transplant Trial

Reuters
·
Jun 25

Natera and Eledon Announce Strategic Partnership for Prospera™ Monitoring in Planned Phase 3 Kidney Transplant Trial

THOMSON REUTERS
·
Jun 25

Natera - Eledon to Initiate Phase 3 Kidney Transplant Trial in Late 2026

THOMSON REUTERS
·
Jun 25

Health Rounds: Drug to prevent organ rejection after kidney transplant tops standard treatment in trial

Reuters
·
Jun 24